SCHEMBL2075487

SCHEMBL2075487

CCN1CCN(c2cc(NC(=O)NC3CCc4ccccc43)ncn2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.47
NTRK1 P04629 2/20 0.46
HDAC3 O15379 1/20 0.45
ABL1 P00519 1/20 0.45
BCR P11274 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
MAPK13 O15264 1/20 0.44
MAPK12 P53778 1/20 0.44
MAPK11 Q15759 1/20 0.44
MAPK14 Q16539 1/20 0.44
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2076656 0.87 KMT2A (0.45) MAPK1NTRK1MAPK13MAPK12MAPK11
SCHEMBL2074482 0.79 KIT (0.46) HDAC3ABL1BCRHDAC4HDAC1
SCHEMBL2074775 0.76 HDAC3 (0.50) HDAC3ABL1BCRHDAC4HDAC1
SCHEMBL2072482 0.75 KIT (0.48) MAPK1HDAC3ABL1BCRHDAC4
SCHEMBL2076498 0.75 MAPT (0.50) HDAC3ABL1BCRHDAC4HDAC1
SCHEMBL2075539 0.73 KIT (0.48) HDAC3ABL1BCRHDAC4HDAC1
SCHEMBL31759268 0.73 DGAT2 (0.47) KMT2AHTR1AMEN1ALDH1A1LMNA
SCHEMBL2076560 0.72 KIT (0.56) HDAC3ABL1BCRHDAC4HDAC1
SCHEMBL2073186 0.72 KIT (0.51) HDAC3ABL1BCRHDAC4HDAC1
SCHEMBL2075182 0.71 KIT (0.46) HDAC3ABL1BCRHDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902184-B2 Piperazinyl pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2011-03-08 US disclosed
EP-2032554-A1 PIPERIDINYL PYRIMIDINE DERIVATIVES F. Hoffmann-Roche AG (CH) 2009-03-11 EP disclosed
WO-2007137955-A1 PIPERIDINYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-12-06 WO disclosed
US-20070281921-A1 Piperidinyl pyrimidine derivatives HOFFMAN-LA ROCHE INC. 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281921-A1 Piperidinyl pyrimidine derivatives HRH2, P2RX5, P2RX3 MAPK1 2242/4885NTRK1 1908/4885HDAC3 1158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.